ENVAFOLIMAB

Search structure
Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: ES1M06M6QH

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Programmed cell death 1 ligand 1 binding agent

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Rectal Neoplasms 3 D012004 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Hepatitis B, Chronic 2 D019694 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Nasopharyngeal Neoplasms 2 D009303 ClinicalTrials
Meningeal Carcinomatosis 2 D055756 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Endometrial Neoplasms 2 D016889 ClinicalTrials
Colonic Neoplasms 2 D003110 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Colonic Neoplasms 2 D003110 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Adenocarcinoma 2 D000230 ClinicalTrials
Gallbladder Neoplasms 2 D005706 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Nasopharyngeal Carcinoma 2 D000077274 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298006
FDA SRS ES1M06M6QH
CONTENTS